Lv11
40 积分 2021-09-03 加入
Circulating tumor DNA as a biomarker in early phase clinical trials
3小时前
待确认
Eleven clinical trials that will shape medicine in 2026
20天前
已完结
Fifty years of monoclonals: the past, present and future of antibody therapeutics
23天前
已完结
Analysis of phase II and phase III clinical trial terminations from 2013 to 2023
29天前
已完结
Trends in target novelty in oncology R&D
1个月前
已完结
Capivasertib plus paclitaxel as first-line treatment for metastatic triple-negative breast cancer: Results from the randomised, global phase III CAPItello-290 trial
1个月前
已完结
US Food and Drug Administration Approval Summary: Trastuzumab Deruxtecan for the Treatment of Adult Patients With Hormone Receptor–Positive, Unresectable or Metastatic Human Epidermal Growth Factor Receptor 2–Low or Human Epidermal Growth Factor Receptor 2–Ultralow Breast Cancer
1个月前
已完结
Precision Oncology: 2025 in Review
1个月前
已完结
Population Pharmacokinetics of Tarlatamab, a Half-Life Extended DLL3-Directed Bispecific T-Cell Engager in Patients with Previously Treated Small Cell Lung Cancer
1个月前
已完结
The rising tide of early-onset colorectal cancer: a comprehensive review of epidemiology, clinical features, biology, risk factors, prevention, and early detection
1个月前
已完结
皖公网安备34019202002308
